Home
About
Overview
Sharing Data
ORCID
Help
History (32)
miRNAs in lung cancer: large roles for small players.
CFAP54 is required for proper ciliary motility and assembly of the central pair apparatus in mice.
Image Enhancement
Tools for assessing outcomes in studies of chronic cough: CHEST guideline and expert panel report.
The emerging therapeutic landscape of relapsed/refractory multiple myeloma.
See All 32 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The emerging therapeutic landscape of relapsed/refractory multiple myeloma.
Tanenbaum B, Miett T, Patel SA. The emerging therapeutic landscape of relapsed/refractory multiple myeloma. Ann Hematol. 2023 Jan; 102(1):1-11.
View in:
PubMed
subject areas
Aged
Antibodies, Bispecific
Antibodies, Monoclonal
Antineoplastic Agents
B-Cell Maturation Antigen
Clinical Trials as Topic
Humans
Immunotherapy, Adoptive
Multiple Myeloma
Neoplasm Recurrence, Local
authors with profiles
Shyam Ajay Patel MD, PhD